Mimics and Diagnostic Pitfalls of Anti‐Adenylate Kinase 5 Limbic Encephalitis
CNS Neuroscience & Therapeutics · 2026
DOI: 10.1002/cns.70757 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2026. Verfasst von Jierui Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Limbic Encephalitis, Autoantibodies, Adenylate Kinase. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Background
The clinical understanding of limbic encephalitis associated with antibodies against adenylate kinase 5 (AK5) remains limited. Misinterpretation of antibody test results may lead to diagnostic errors and inappropriate management. We aim to assess the frequency of anti‐AK5 encephalitis overdiagnosis and identify common diagnostic pitfalls.
Methods
Cases of confirmed and mimicking anti‐AK5 limbic encephalitis from January 2021 to July 2024 using established criteria for autoimmune encephalitis (AE) were reviewed. AK5 mimics were defined as patients initially suspected of AE with a positive AK5 autoantibody result, but who ultimately received an alternative final diagnosis.
Results
A total of 21 patients were included (57.1% female; median age 34 years; range 14–82). Only 3 patients (14%) were diagnosed with definite anti‐AK5 limbic encephalitis, while 18 patients (86%) were classified as AK5 mimics. Serum autoantibodies were predominantly of the IgG3 subclass, with titers ranging from 1:10 to 1:100. The mimics included primary psychiatric disorders (22%), central nervous system (CNS) infections (22%), other inflammatory disorders (28%), epilepsy (16%), neurodegenerative diseases (6%) and metabolic encephalopathy (6%). The most frequent confounding factor in misdiagnosis was the presence of prominent psychiatric and behavioral symptoms, seen in 50% (9 of 18) of AK5 mimics. The second most common confounder was the presence of low serum antibody titers or isolated serum positivity without corresponding cerebrospinal fluid (CSF) findings (< 1:100), observed in 94% (17 of 18) of mimics.
Conclusion
Mimics of anti‐AK5 encephalitis are common and that misdiagnosis is often driven by non‐specific symptoms and clinically irrelevant antibody results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, West China Hospital of Sichuan University, Chengdu, China.
- Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, China.
- Department of Laboratory Medicine, The First People's Hospital of Longquanyi District, Chengdu, China.
ORCID-Profile: Minjin Wang, Dong Zhou, Jinmei Li
Förderung
- China Postdoctoral Science Foundation
Zitieren
APA
Wang, J., Yi, T., Wang, G., Wang, M., Zhou, D., & Li, J. (2026). Mimics and Diagnostic Pitfalls of Anti‐Adenylate Kinase 5 Limbic Encephalitis. CNS Neuroscience & Therapeutics. https://doi.org/10.1002/cns.70757
Vancouver
Wang J, Yi T, Wang G, Wang M, Zhou D, Li J. Mimics and Diagnostic Pitfalls of Anti‐Adenylate Kinase 5 Limbic Encephalitis. CNS Neuroscience & Therapeutics. 2026. doi:10.1002/cns.70757
BibTeX
@article{Wang2026,
author = {Wang, Jierui and Yi, Tong and Wang, Guoyu and Wang, Minjin and Zhou, Dong and Li, Jinmei},
title = {Mimics and Diagnostic Pitfalls of Anti‐Adenylate Kinase 5 Limbic Encephalitis},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
doi = {10.1002/cns.70757}
}
EUVIMED